91 related articles for article (PubMed ID: 12922167)
1. Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance.
Smith SA; Sreenivasan R; Krishnasamy G; Judge KW; Murthy KH; Arjunwadkar SJ; Pugh DR; Kotwal GJ
Biochim Biophys Acta; 2003 Aug; 1650(1-2):30-9. PubMed ID: 12922167
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.
Bernet J; Mullick J; Panse Y; Parab PB; Sahu A
J Virol; 2004 Sep; 78(17):9446-57. PubMed ID: 15308738
[TBL] [Abstract][Full Text] [Related]
3. Humanized recombinant vaccinia virus complement control protein (hrVCP) with three amino acid changes, H98Y, E102K, and E120K creating an additional putative heparin binding site, is 100-fold more active than rVCP in blocking both classical and alternative complement pathways.
Ghebremariam YT; Odunuga OO; Janse K; Kotwal GJ
Ann N Y Acad Sci; 2005 Nov; 1056():113-22. PubMed ID: 16387681
[TBL] [Abstract][Full Text] [Related]
4. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein.
Isaacs SN; Argyropoulos E; Sfyroera G; Mohammad S; Lambris JD
J Virol; 2003 Aug; 77(15):8256-62. PubMed ID: 12857894
[TBL] [Abstract][Full Text] [Related]
5. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.
Ahmad M; Raut S; Pyaram K; Kamble A; Mullick J; Sahu A
J Immunol; 2010 Nov; 185(10):6128-37. PubMed ID: 20956343
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation.
Anderson JB; Smith SA; van Wijk R; Chien S; Kotwal GJ
Transpl Immunol; 2003; 11(2):129-35. PubMed ID: 12799195
[TBL] [Abstract][Full Text] [Related]
7. Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity.
Kotwal GJ
Protein Cell; 2010 Dec; 1(12):1084-92. PubMed ID: 21213103
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia complement control protein: multi-functional protein and a potential wonder drug.
Jha P; Kotwal GJ
J Biosci; 2003 Apr; 28(3):265-71. PubMed ID: 12734405
[TBL] [Abstract][Full Text] [Related]
9. A new map of glycosaminoglycan and C3b binding sites on factor H.
Schmidt CQ; Herbert AP; Kavanagh D; Gandy C; Fenton CJ; Blaum BS; Lyon M; Uhrín D; Barlow PN
J Immunol; 2008 Aug; 181(4):2610-9. PubMed ID: 18684951
[TBL] [Abstract][Full Text] [Related]
10. Identification of complement regulatory domains in vaccinia virus complement control protein.
Mullick J; Bernet J; Panse Y; Hallihosur S; Singh AK; Sahu A
J Virol; 2005 Oct; 79(19):12382-93. PubMed ID: 16160165
[TBL] [Abstract][Full Text] [Related]
11. Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.
Yadav VN; Pyaram K; Mullick J; Sahu A
J Virol; 2008 Apr; 82(7):3283-94. PubMed ID: 18216095
[TBL] [Abstract][Full Text] [Related]
12. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense.
Smith SA; Mullin NP; Parkinson J; Shchelkunov SN; Totmenin AV; Loparev VN; Srisatjaluk R; Reynolds DN; Keeling KL; Justus DE; Barlow PN; Kotwal GJ
J Virol; 2000 Jun; 74(12):5659-66. PubMed ID: 10823874
[TBL] [Abstract][Full Text] [Related]
13. Glycosylated and nonglycosylated complement control protein of the lister strain of vaccinia virus.
Meseda CA; Kuhn J; Atukorale V; Campbell J; Weir JP
Clin Vaccine Immunol; 2014 Sep; 21(9):1330-8. PubMed ID: 25030055
[TBL] [Abstract][Full Text] [Related]
14. Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.
Ganesh VK; Smith SA; Kotwal GJ; Murthy KH
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8924-9. PubMed ID: 15178763
[TBL] [Abstract][Full Text] [Related]
15. Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity.
Bernet J; Ahmad M; Mullick J; Panse Y; Singh AK; Parab PB; Sahu A
Vaccine; 2011 Oct; 29(43):7435-43. PubMed ID: 21803094
[TBL] [Abstract][Full Text] [Related]
16. Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.
Girgis NM; Dehaven BC; Fan X; Viner KM; Shamim M; Isaacs SN
J Virol; 2008 May; 82(9):4205-14. PubMed ID: 18287241
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP).
Rosengard AM; Alonso LC; Korb LC; Baldwin WM; Sanfilippo F; Turka LA; Ahearn JM
Mol Immunol; 1999 Jul; 36(10):685-97. PubMed ID: 10509819
[TBL] [Abstract][Full Text] [Related]
18. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
Kumar J; Yadav VN; Phulera S; Kamble A; Gautam AK; Panwar HS; Sahu A
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724763
[TBL] [Abstract][Full Text] [Related]
19. Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance.
Yu H; Muñoz EM; Edens RE; Linhardt RJ
Biochim Biophys Acta; 2005 Nov; 1726(2):168-76. PubMed ID: 16125850
[TBL] [Abstract][Full Text] [Related]
20. Vaccinia virus complement control protein increases early bacterial clearance during experimental peritonitis.
Scott MJ; Burch PT; Jha P; Peyton JC; Kotwal GJ; Cheadle WG
Surg Infect (Larchmt); 2003; 4(4):317-26. PubMed ID: 15012858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]